🇮🇳 Catapres-Tts-1 in India

Catapres-Tts-1 (CLONIDINE) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

Catapres-Tts-1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in India

Frequently asked questions

Is Catapres-Tts-1 approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for Catapres-Tts-1 in India?

Lavipharm is the originator. The local marketing authorisation holder may differ — check the official source linked above.